PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

ANP have previously reported that ATL1103 injection suppressed...

  1. wormy
    2,405 Posts.
    clock Created with Sketch.
    22/08/11
    06:52
    Post #: 8852244






    ANP have previously reported that ATL1103 injection suppressed circulating levels of IGF-I in primates and that toxicology studies have been completed supporting the Company?s plans to move ATL1103 into clinical development



    (.>_<)


    ANP Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
M2R Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
1 119 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273239 2
View Market Depth
Last trade - 11.56am 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.